Alnylam Chief Commercial Officer Tolga Tanguler Departs
Alnylam Pharmaceuticals announced its Chief Commercial Officer is leaving as the company authorizes a $1 billion share repurchase program.
Massachusetts Tech News
Coverage of tech in Massachusetts focuses on hardware and software innovation, industry earnings, regulatory debates and the societal impact of new tools. Reporting follows the breakthroughs at regional firms and the policy changes that shape the sector.
Robotics
Live Poll
Would you trust a robot to perform a diagnostic test inside your body?
MIT Robot Navigates Pig Small Intestine
A snake-inspired device called BIOSENTER delivered dyes and collected tissue biopsies in pig models without damaging the intestinal lining.
Artificial Intelligence
Live Poll
Should states pass their own AI regulations rather than waiting for federal guidance?
Massachusetts Considers New AI Regulation Bill
The Mass Wins Act proposes independent safety evaluations for large AI models to prevent potential harm.
Biotech
XenImmune Tests GBI SmartScale for Protein Production
XenImmune Therapeutics and GBI Biomanufacturing agreed to assess GBI's SmartScale system for producing XenImmune's AGF protein molecules.
Cybersecurity
Live Poll
Should companies be held legally liable for the security of employee data after a breach?
Judge Allowed Sensata Technologies Lawsuit to Proceed
A federal judge ruled that a class action lawsuit over a massive data breach can move forward in Massachusetts.
Telecommunications
Live Poll
Do you support the use of mobile camera trailers to detect wrong-way drivers in your area?
Massachusetts Deployed Mobile Wrong-Way Detection Units
MassDOT has introduced mobile trailers featuring radar sensors to improve safety on state highways.
More in Tech
Massachusetts reporting spans industry growth, product innovation, the regulatory landscape and the shifting digital infrastructure across the state. Coverage reaches from the major innovation hubs to the specialized research corridors across the state. Innovation in biotechnology and robotics creates a unique cycle of specialized reporting that distinguishes the region. Academic research funding and its transition into commercial enterprise define the pace of technological development.